Home > PS Ratio > MANKIND PHARMA

MANKIND PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of MANKIND PHARMA is 9.91.

Share Price ₹2,726.5Nov 07,2024
Market Cap ₹109,221.6 Cr
Sales-TTM₹11,018.0 CrTTM-Consolidated Results
Price/Sales9.91xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of MANKIND PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MANKIND PHARMA is calculated as :

Current Market Cap [ ₹109,221.6 Cr] as on Nov 07,2024

(/) Sales [ ₹11,018.0 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.91x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MANKIND PHARMA , the investors are currently willing to pay '9.91 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MANKIND PHARMA !

The chart below summarizes the trend in P/S Ratio of MANKIND PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of MANKIND PHARMA


PS Ratio Performance Analysis for MANKIND PHARMA

- MANKIND PHARMA 's latest p/e ratio is 9.91x.

- MANKIND PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.78x.

- MANKIND PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MANKIND PHARMA 's p/e ratio peaked in Mar2024 at 8.9x.

- MANKIND PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does MANKIND PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MANKIND PHARMA 11,018.09.91109,221.6
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.54429,841.0
CIPLA LTD26,512.04.79127,063.0
DR REDDYS LABORATORIES LTD30,084.93.57107,398.0
ZYDUS LIFESCIENCES LTD20,615.34.7597,866.3
DIVIS LABORATORIES LTD8,185.019.33158,179.0
TORRENT PHARMACEUTICALS LTD11,225.09.53106,928.0
LUPIN LTD20,797.14.6396,282.2
AUROBINDO PHARMA LTD29,718.42.6478,437.3
ABBOTT INDIA LTD6,066.19.9160,116.9
ALKEM LABORATORIES LTD12,731.75.3768,407.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MANKIND PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.64x
Max industry PS 19.33x
Median industry PS 5.37x
Average industry PS 7.54x



You may also like the below Video Courses